Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2025Frontiers in EndocrinologyOpen Access

A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways

View Full Paper
Ask AI
Bookmark
Share

Authors

CPChristine ParkYKYushin KimSRSawye Raygani

Discussion

Loading...

Member takes

Overview

Review highlights the effectiveness of anti-obesity pharmacotherapy in treating obesity, suggesting novel combination strategies.

Key Points

  • Emerging agents show promise in treating obesity, with some demonstrating significant effectiveness through innovative mechanisms.
  • Lifestyle interventions often fail long-term, while metabolic bariatric surgery provides effective, but underutilized solutions for severe obesity.
  • Safe and effective anti-obesity medications are emerging, improving treatment strategies for metabolic diseases like obesity.
  • The review underscores the rapid development of new pharmacotherapies that target multiple receptor pathways, expanding treatment options.

Cite This Study

Park et al. (2025) studied this question.

synapsesocial.com/papers/68d41d9b713b0b5dfea668edhttps://doi.org/10.3389/fendo.2025.1630199
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines2025
  2. 2INNOVATIONS IN OBESITY TREATMENT – GLP – 1 PHARMACOTHERAPY AND BARIATRIC SURGERY2025
  3. 3Incretin Drug Revolution: The Challenges of Hope2025
  4. 4Novel oral agents in anti‐obesity pharmacotherapy: A narrative review2025
  5. 5OBESITY DISEASE - NON-SURGICAL TREATMENT METHODS - A LITERATURE REVIEW2025